Repository logo
  • Research Outputs
  • Researchers
  • Schools
    Felizberta Lo Padilla Tong School of Social SciencesIp Ying To Lee Yu Yee School of Humanities and LanguagesRita Tong Liu School of Business and Hospitality ManagementS.K. Yee School of Health SciencesYam Pak Charitable Foundation School of Computing and Information Sciences
  • Help
Repository logo
  1. Home
  2. Health Sciences
  3. HS Publication
  4. The central actions of the glucagon-like peptide-1 receptor agonist, exendin-4, in Suncus murinus: A telemetric study
 
  • Details

The central actions of the glucagon-like peptide-1 receptor agonist, exendin-4, in Suncus murinus: A telemetric study

Author(s)
Chan, Stella Sze Wa  
Lu, Zengbing
Author(s)
Tu, L.
Ngan, M. P.
Rudd, J. A.
Date Issued
2018
Conference
18th World Congress of Basic and Clinical Pharmacology (WCP2018)
Abstract
Introduction. GLP-1 receptor agonists for the treatment of type 2 diabetes can be associated with nausea, emesis and reduced appetite in man. The GLP-1 receptor agonist, exendin-4, inhibits feeding and water intake, and induces emesis in Suncus murinus. Aims. The aim of this study is to investigate the central actions of GLP-1 receptor agonist, exendin-4 by using radiotelemetry in Suncus murinus. Methods. A guide cannula was implanted into the lateral ventricle under anesthesia. After seven days, two biopotential wires of a telemetric transmitter were implanted into the antrum and its pressure catheter was implanted into the left carotid artery under anesthesia. After seven days recovery, baseline recordings were made for 12 h before exendin-4 (0.03, 0.3 and 3 nmol, i.c.v.) or saline (5 μl, i.c.v.) injection. Behavioral observation and telemetric recordings were continued for a further 24 h. Results. Central administration of exendin-4 significantly inhibited food and water intake at 4-5 h and 5-24 h post-injection, and also prevented 24 h body weight gain; these effects were dose-related. In addition, exendin-4 also dose-dependently induced emesis. The telemetric recordings showed that exendin-4 increased systolic and diastolic blood pressure, and increased heart rate and body temperature during the first 4 h following injection. Exendin-4 at 0.3 and 3 nmol, i.c.v., also significantly increased the dominant frequency of gastric slow waves during the first 4 h. Conclusions. This study showed that central GLP-1 receptors may be important in emesis control, food and water intake, and the modulation of cardiovascular function and gastric slow waves. The studies were fully supported by a grant from the Research Grants Council of the Hong Kong SAR, China (Project no. UGC/FDS11/M02/15).
URI
https://repository.sfu.edu.hk/handle/sfu/249
SFU Affiliated Publication
Yes
Availability at SFU Library

No database links found.

Responsible Use of E‑Resources | Privacy Policy | Disclaimer
© SFU Library. All Rights Reserved.
SFU Library